loading

Day One Biopharmaceuticals Inc 주식(DAWN)의 최신 뉴스

pulisher
Jun 19, 2025

Day 8 of Loss Streak for Day One Biopharmaceuticals Stock with -11% Return (vs. -49% YTD) [6/18/2025] - Trefis

Jun 19, 2025
pulisher
Jun 16, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of “Buy” by Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Takes Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Has $260,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Where are the Opportunities in (DAWN) - news.stocktradersdaily.com

Jun 13, 2025
pulisher
Jun 11, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Transcript : Day One Biopharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Day One Appoints Michael Vasconcelles As Head Of Research And Development - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Day One Biopharmaceuticals (DAWN) Welcomes New R&D Leader | DAWN Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

Day One Taps ImmunoGen Executive to Lead R&D: 25-Year Oncology Expert Joins Cancer Drug Developer - Stock Titan

Jun 10, 2025
pulisher
Jun 08, 2025

H.C. Wainwright Maintains Buy Rating on Day One Biopharmaceuticals (DAWN), Keeps PT - MSN

Jun 08, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Decreases Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Squarepoint Ops LLC Acquires New Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

JonesTrading Maintains Buy Rating on Day One Biopharmaceuticals (DAWN) Following Ojemda’s FDA Approval - Insider Monkey

Jun 05, 2025
pulisher
Jun 04, 2025

Day One Biopharmaceuticals: Strong Ojemda Potential In Q2 And Solid Rationale For DAY-301 - Seeking Alpha

Jun 04, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Lowers Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Bought by Millennium Management LLC - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Increases Stock Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 1,894 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 30, 2025
pulisher
May 29, 2025

Cetera Investment Advisers Has $400,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 29, 2025
pulisher
May 25, 2025

36,685 Shares in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Bought by BNP Paribas Financial Markets - Defense World

May 25, 2025
pulisher
May 22, 2025

D. E. Shaw & Co. Inc. Increases Stock Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 22, 2025
pulisher
May 22, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Rating of “Buy” from Brokerages - Defense World

May 22, 2025
pulisher
May 20, 2025

We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth - Yahoo Finance

May 20, 2025
pulisher
May 20, 2025

Northern Trust Corp Grows Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 20, 2025
pulisher
May 19, 2025

Day one Biopharmaceuticals officer sells $24,574 in stock By Investing.com - Investing.com Nigeria

May 19, 2025
pulisher
May 19, 2025

Day one Biopharmaceuticals officer sells $24,574 in stock - Investing.com

May 19, 2025
pulisher
May 19, 2025

Day One Biopharmaceuticals Executives Sell Shares to Cover Tax Liabilities - TradingView

May 19, 2025
pulisher
May 15, 2025

Day one biopharmaceuticals highlights OJEMDA revenue growth and pipeline progress in Q1 2025 - MSN

May 15, 2025
pulisher
May 14, 2025

Day One Biopharmaceuticals Insider Lowered Holding By 20% During Last Year - simplywall.st

May 14, 2025
pulisher
May 14, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stake Decreased by Voya Investment Management LLC - Defense World

May 14, 2025
pulisher
May 13, 2025

Transcript : Day One Biopharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now? - MSN

May 13, 2025
pulisher
May 12, 2025

10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 11, 2025

Trend Tracker for (DAWN) - news.stocktradersdaily.com

May 11, 2025
pulisher
May 11, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Down – Here’s What Happened - Defense World

May 11, 2025
pulisher
May 10, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Purchased by Dimensional Fund Advisors LP - Defense World

May 10, 2025
pulisher
May 10, 2025

Research Analysts Issue Forecasts for DAWN Q2 Earnings - Defense World

May 10, 2025
pulisher
May 10, 2025

Needham & Company LLC Cuts Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target to $27.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

Research Analysts Set Expectations for DAWN Q2 Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Is Day One Biopharmaceuticals, Inc. (DAWN) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Analysts Issue Forecasts for DAWN Q1 Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up After Earnings Beat - Defense World

May 08, 2025
pulisher
May 08, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Mariner LLC - Defense World

May 08, 2025
pulisher
May 08, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 12-Month Low Following Analyst Downgrade - Defense World

May 08, 2025
pulisher
May 07, 2025

Day One Biopharma’s Earnings Call Highlights Growth - TipRanks

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals (DAWN) Target Price Adjusted to $26 | DAWN Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Needham Adjusts Price Target for DAWN to $27, Maintains Buy Rati - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

MetLife Investment Management LLC Raises Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals earnings beat by $0.07, revenue fell short of estimates - Investing.com Canada

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals Reports Strong Q1 2025 Results - TipRanks

May 07, 2025
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
자본화:     |  볼륨(24시간):